精氨酸加压素受体拮抗剂在慢性心力衰竭伴发低钠血症应用进展

被引：7

作者：

徐少东

施有为

机构：

[1] 合肥市第一人民医院心内科

来源：

心血管病学进展 | 2009年 / 30卷 / 04期

关键词：

精氨酸加压素; 受体拮抗剂; 慢性心力衰竭; 低钠血症;

D O I：

暂无

中图分类号：

R541.61 [];

学科分类号：

摘要：

慢性心力衰竭是许多心血管疾病终末状态的表现,而低钠血症是慢性心力衰竭中最常见的电解质紊乱。大量循证医学证据表明低钠血症是慢性心力衰竭患者病死率及再次住院率的独立预测因子,而传统的治疗低钠血症的方法在慢性心力衰竭中应用效果不佳且不良反应较多。作为新一代的利尿剂,研究表明精氨酸加压素受体拮抗剂在纠正慢性心力衰竭患者的低钠血症中具有积极作用,现将对此进行综述。

引用

页码：669 / 672

页数：4

共 5 条

[1]

Observations regarding the use of the aquaretic agent conivaptan for treatment of hyponatremia [J].

Metzger, Benjamin L. ;

DeVita, Maria V. ;

Michelis, Michael F. .

INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (03) :725-730

[2]

Pharmacokinetics; Pharmacodynamics; and Safety of Tolvaptan; a Nonpeptide AVP Antagonist; During Ascending Single-Dose Studies in Healthy Subjects.[J].Susan E. Shoaf;Zhao Wang;Patricia Bricmont;Suresh Mallikaarjun.The Journal of Clinical Pharmacology.2007, 12

[3]

Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.[J].Joseph Rossi;Melike Bayram;James E. Udelson;Donald Lloyd‐Jones;Kirkwood F. Adams;Christopher M. Oconnor;Wendy Gattis Stough;John Ouyang;David D. Shin;Cesare Orlandi;Mihai Gheorghiade.Acute Cardiac Care.2007, 2

[4]

Aquaretic Effect of Lixivaptan; an Oral; Non-Peptide; Selective V2 Receptor Vasopressin Antagonist; in New York Heart Association Functional Class II and III Chronic Heart Failure Patients.[J].William T. Abraham;Alireza A. Shamshirsaz;Kim McFann;Ron M. Oren;Robert W. Schrier.Journal of the American College of Cardiology.2006, 8

[5]

Vasopressin: A new target for the treatment of heart failure [J].

Lee, CR ;

Watkins, ML ;

Patterson, JH ;

Gattis, W ;

O'Connor, CM ;

Gheorghiade, M ;

Adams, KF .

AMERICAN HEART JOURNAL, 2003, 146 (01) :9-18

← 1 →